Skip to content

The ImPress study: Impact of a nurse-delivered intervention to identify primary care patients with hypertension and provide care directed at improving blood pressure

The ImPress study: Efficacy of a nurse-delivered intervention to identify primary care patients with hypertension and target care towards improved blood pressure control.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000169246
Acronym
ImPress
Enrollment
36
Registered
2018-02-02
Start date
2018-10-01
Completion date
2019-12-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project will comprise of a randomised control trial (RCT). The hypothesis will be tested by randomly allocating participants into two groups; the ImPress intervention and a control group. Clinical differences between these groups will be assessed at 6 and 12 months follow-up. The primary goal of conducting this trial is to evaluate if the ImPress intervention is more effective than usual care in achieving optimal blood pressure control, medication adherence, behavioural risk factors and body mass index in general practice. Randomisation will occur at a practice level and data will be collected by the GPN at baseline, six and twelve months when patients attend the practice. A total sample of 200 patients across 20 practices will be sought. .Once Practices have been recruited, participating GPNs will conduct a structured electronic search of the practice medical record database to identify a list of eligible patients. Following the assessment visit and study enrollment, patients will attend three face to face GPN appointments and two telephone consultations throughout intervention. All consultations will be underpinned by a person centred approach with the GPN utilising motivational interviewing techniques and the 5 As’ to build rapport, set goals and offer support for self-management. While the aim of first GPN consultation is to record baseline BP, biometric measures and lifestyle risks, this initial encounter is an opportunity to build rapport and shared understanding. Subsequent visits will focus on individualised action planning in partnership with the patient, goal setting and feedback on progress. Templates to structure each nursing assessment will be uploaded to the practices computerised clinical files in Director or Best Practice. GPNs will be encouraged to collaborate with the participating GP(s) to share information around the nursing care being provided.

Interventions

Pre intervention education for participating General Practice nurses (GPNs) will be provided prior to implementation. This will comprise of an all day workshop covering hypertension etiology, blood pressure management strategies, motivational interviewing techniques and Clinical Auditing Tool application. The research team facilitating the workshops have extensive skills and expertise in primary health care across clinical, academic and educational domains. Following the assessment visit and stu

Pre intervention education for participating General Practice nurses (GPNs) will be provided prior to implementation. This will comprise of an all day workshop covering hypertension etiology, blood pressure management strategies, motivational interviewing techniques and Clinical Auditing Tool application. The research team facilitating the workshops have extensive skills and expertise in primary health care across clinical, academic and educational domains. Following the assessment visit and study enrollment, patients will attend three face to face GPN appointments and two telephone consultations throughout intervention. All consultations will be underpinned by a person centred approach with the GPN utilising motivational interviewing techniques and the 5 As’ to build rapport, set goals and offer support for self-management. The 5 A's framework enables the GPN to structure visits through the following steps- Asses, Advise, Agree, Assist and Arrange. The 3 face to face appointments will be conducted over a 6 month period, 1 hour in duration arranged at a mutually convenient time for the GPN and patient. The GPN will provide 2 telephone calls no longer than 15 minutes in duration over the 6 month intervention period at a time convenient to the patient. While the aim of first GPN consultation is to record baseline BP, biometric measures and lifestyle risks, this initial encounter is an opportunity to build rapport and shared understanding. Subsequent visits will focus on individualised action planning in partnership with the patient, goal setting and feedback on progress. GPs contribution will involve medication optimisation in line with Australian hypertension guidelines (National Heart Foundation of Australia, 2016, Guideline for the diagnosis and management of hypertention in adults) Templates to structure each nursing assessment will be uploaded to the practices computerised clinical files in Director or Best Practice .To streamline the data entry process, templates will have the capacity to pre-populate existing patient details. GPNs will be encouraged to collaborate with the participating General Practitioners (GP) to share information around the nursing care being provided. Patients participating in the intervention will keep a copy of their action plan which will be annotated at each visit. This will record their progress to date and ongoing goals.

Sponsors

Professor Elizabeth Halcomb
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
45 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

• Active patients according to the Royal College of General Practitioners definition; attending the practice 3 or more times in the last 2 years. • Diagnosis of hypertension, are at high risk of a CVD event and have uncontrolled hypertension. This study defines uncontrolled hypertension in line with the Heart Foundation Guidelines; office BP >140/90 mmHg. High CVD risk is defined as calculated 5 year absolute CVD risk >15% or the presence of cardiovascular disease as per National Vascular Disease Prevention Alliance (NVDPA) guide.

Exclusion criteria

Individuals who are unable to read and comprehend health information in the English Language.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 3, 2026